Zhaoke Ophthalmology Past Earnings Performance
Past criteria checks 0/6
Zhaoke Ophthalmology has been growing earnings at an average annual rate of 4.9%, while the Pharmaceuticals industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 94.1% per year.
Key information
4.9%
Earnings growth rate
45.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 5.6% |
| Revenue growth rate | 94.1% |
| Return on equity | -18.8% |
| Net Margin | -2,053.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Zhaoke Ophthalmology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 19 | -385 | 136 | 333 |
| 30 Sep 23 | 15 | -433 | 132 | 367 |
| 30 Jun 23 | 11 | -480 | 129 | 401 |
| 31 Mar 23 | 6 | -444 | 122 | 349 |
| 31 Dec 22 | 0 | -407 | 116 | 296 |
| 30 Sep 22 | 0 | -355 | 120 | 247 |
| 30 Jun 22 | 0 | -303 | 125 | 198 |
| 31 Mar 22 | 0 | -1,216 | 152 | 209 |
| 31 Dec 21 | 0 | -2,130 | 179 | 220 |
| 30 Sep 21 | 0 | -2,210 | 171 | 199 |
| 30 Jun 21 | 0 | -2,648 | 138 | 167 |
| 31 Mar 21 | 0 | -1,688 | 87 | 124 |
| 31 Dec 20 | 0 | -727 | 37 | 82 |
| 30 Sep 20 | 0 | -607 | 12 | 73 |
| 31 Dec 19 | 0 | -122 | 6 | 93 |
Quality Earnings: 6622 is currently unprofitable.
Growing Profit Margin: 6622 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6622 is unprofitable, but has reduced losses over the past 5 years at a rate of 4.9% per year.
Accelerating Growth: Unable to compare 6622's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6622 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (1.3%).
Return on Equity
High ROE: 6622 has a negative Return on Equity (-18.8%), as it is currently unprofitable.